Short- and long-term safety of the 2 x 10(6) CD34+ cells/kg threshold for hematopoietic reconstitution after high-dose chemotherapy and peripheral blood progenitor cell support

Ann Oncol. 2002 Jun;13(6):983-5. doi: 10.1093/annonc/mdf181.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigens, CD34 / analysis*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Evaluation Studies as Topic
  • Female
  • Hematopoiesis / drug effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Neoplasm Staging
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Prognosis
  • Risk Assessment
  • Treatment Outcome

Substances

  • Antigens, CD34